Thymidine‐Auxotrophic Salmonella Enables Selective Tumor Colonization and Adenosine Depletion for Cancer Immunotherapy
Advanced Materials · 2026-04 · 38 (23)
DOI: 10.1002/adma.202519052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 25.03.2026. Verfasst von Chenxuan Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, Department of Andrology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, …. Hauptthemen laut MEDLINE: Adenosine, Immunotherapy, Salmonella typhimurium, Thymidine. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Science and Technology Major Project on Innovative Biopharmaceutical, National Key Research and Development Program of China.
Abstract (Originalsprache)
Bacterial therapy offers unique advantages in tumor targeting and intratumoral payload delivery, yet its clinical translation remains hampered by limited selectivity and systemic toxicity. Here, we constructed a thymidine‐auxotrophic strain of Salmonella typhimurium (TK VNP), in which bacterial growth is strictly dependent on exogenous deoxythymidine monophosphate (dTMP). We show that dTMP is consistently enriched in the tumor microenvironment (TME) due to high nucleotide turnover and cell lysis, enabling TK VNP to selectively proliferate in the tumor while minimizing colonization in normal organs. This metabolic dependency enhanced systemic safety and improved the tumor‐targeting index by nearly tenfold compared with the parental strain. On this safety‐enhanced chassis, we introduced an adenosine degradation module to express adenosine deaminase (ADD) in different localizations‐cytoplasmic (cTKA VNP), secreted (sTKA VNP), and surface‐anchored (wTKA VNP) to metabolize immunosuppressive adenosine (ADO) into inosine (INO). These strains efficiently promoted CD8 + T cell infiltration and activation, and reduced exhaustion markers such as PD‐1 and TIM‐3. Moreover, TKA VNP synergized with immune checkpoint blockade and radiotherapy to induce durable tumor regression. This work establishes a metabolically gated bacterial therapeutic platform that integrates tumor‐restricted replication with localized immunometabolic modulation, addressing key challenges in the safe and effective clinical application of bacterial cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology, Department of Andrology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing University, Nanjing, China.
- Medical 3D Printing Center, Orthopaedic Institute, Department of Orthopaedic Surgery, The First Affiliated Hospital, School of Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, China.
- Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Andrology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
- Chemistry and Biomedicine Innovation Center, Nanjing University, Nanjing, China.
- Jiangsu Key Laboratory for Cardiovascular Information and Health Engineering Medicine, Institute of Clinical Medicine, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing, China.
ORCID-Profile: Xiaoxiang Guan, Jinhui Wu
Förderung
- National Natural Science Foundation of China
- Jiangsu Provincial Science and Technology Major Project on Innovative Biopharmaceutical
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
Zitieren
APA
Zhao, C., Yao, Y., Wang, C., Yang, M., Wang, Y., Feng, Z., Liu, A., Zhao, C., Shi, Y., Rui, X., Guan, X., Zhao, X., & Wu, J. (2026). Thymidine‐Auxotrophic Salmonella Enables Selective Tumor Colonization and Adenosine Depletion for Cancer Immunotherapy. Advanced Materials, 38(23). https://doi.org/10.1002/adma.202519052
Vancouver
Zhao C, Yao Y, Wang C, Yang M, Wang Y, Feng Z, et al. Thymidine‐Auxotrophic Salmonella Enables Selective Tumor Colonization and Adenosine Depletion for Cancer Immunotherapy. Advanced Materials. 2026;38(23). doi:10.1002/adma.202519052
BibTeX
@article{Zhao2026,
author = {Zhao, Chenxuan and Yao, Yesong and Wang, Chao and Yang, Mingkang and Wang, Yuchen and Feng, Zhuo and Liu, Ansheng and Zhao, Chuan and Shi, Yilong and Rui, Xuehui and Guan, Xiaoxiang and Zhao, Xiaozhi and Wu, Jinhui},
title = {Thymidine‐Auxotrophic Salmonella Enables Selective Tumor Colonization and Adenosine Depletion for Cancer Immunotherapy},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {23},
doi = {10.1002/adma.202519052}
}
EUVIMED